3,4-dihydroxyphenylglycol has been researched along with Panic Disorder in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alvarenga, M; Barton, D; Brenchley, C; Dawood, T; Esler, M; Guo, L; Haikerwal, D; Hastings, J; Jennings, G; Kalff, V; Kaye, D; Kelly, M; Lambert, E; Lambert, G; Pier, C; Richards, J; Socratous, F; Wiesner, G | 1 |
1 trial(s) available for 3,4-dihydroxyphenylglycol and Panic Disorder
Article | Year |
---|---|
Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor.
Topics: Adult; Brain; Case-Control Studies; Catheterization, Central Venous; Catheterization, Peripheral; Cerebrovascular Circulation; Citalopram; Genotype; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic Disorder; Research Design; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon | 2007 |